Advanced search
Publication Cover
Drug Delivery Volume 12, 2005 - Issue 6
Submit an article Journal homepage
1,248
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Effect of Co-Solvents on the Controlled Release of Calcitonin Polypeptide from In Situ Biodegradable Polymer Implants

Sunil Prabhu College of Pharmacy, Western University of Health Sciences, Pomona, California, USA
,
Lan P. Tran College of Pharmacy, Western University of Health Sciences, Pomona, California, USA
&
Guru V. Betageri College of Pharmacy, Western University of Health Sciences, Pomona, California, USA
Pages 393-398 | Received 13 Jul 2004, Accepted 20 Sep 2004, Published online: 10 Oct 2008

REFERENCES

  • Bleiberg B., Beers T. R., Persson M., Miles J. Metabolism of triacetin-derived acetate in dogs. Am. J. Clin. Nutr. 1993; 58: 908–911, [PUBMED], [INFOTRIEVE], [CSA]
  • Chandrashekhar G., Udupa N. Biodegradable injectable implants for long term drug delivery using poly (lactic-co-glycolic) acid copolymers. J. Pharm. Pharmacol. 1996; 48: 669–674, [CSA]
  • Chern R. T., Zingermann J. R. Liquid polymeric compositions for controlled release of bioactive substances. 1999, WO Publications Number 9947073
  • Cherng-Chyi Fu R., Lidgate D. M., Whatley J. L., McCullough T. The biocompatibility of parenteral vehicles in vivo/in vitro screening comparison and effect of excipients on hemolysis. J. Parent. Sci. Technol. 1998; 41(5)164–168, [CSA]
  • Cleland J. L. Injectable gels for local and systemic delivery of proteins. Abstract #0221, Controlled Release Society Annual meeting, San Diego, CA., 2001
  • Crowther M. A., Pilling A., Owen K. The evaluation of glycofurols as a vehicle for use in toxicity studies. Hum. Exp. Toxicol. 1997; 16: 406, [CSA]
  • Davis S. S., Ilum L. Polymeric microspheres as drug carriers. Biomaterials 1988; 9: 111–115, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Dunn R. L., English J. P., Cowsar D. R., Vanderbelt D. D. Biodegradable in situ forming implants and methods of producing the same. U.S. Patent 5 278 201 11, 1994
  • Dunn R. L., Tipton A. J., Southard G. L., Rogers J. A. Biodegradable polymer composition. U. S. Patent 5 599 552, 1997
  • Eastell R. Treatment of menopausal osteoporosis. N. Eng. J. Med. 1998; 338: 736, [CSA], [CROSSREF]
  • Eliaz R. E., Kost J. Characterization of a polymeric PLGA—injectable implant delivery system for the controlled release of proteins. J. Biomed. Mat. Res. 2000; 50: 388–396, [CSA], [CROSSREF]
  • Eliaz R. E., Wallach D., Kost J. Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in vivo. Pharm. Res. 2000; 17(12)1546–1550, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Graham D., Brodbeck K. J., McHugh A. J. Phase inversion dynamics of PLGA solutions related to drug delivery. J. Contrd. Rel. 1999; 58: 233–245, [CSA], [CROSSREF]
  • ICH Topic Q3C (M). Maintenance of note for guidance on impurities: residual solvents (CPMP, ICH/283/95). European Agency for the Evaluation of Medical Products, London, UK., 2000
  • Jain R. A., Rhodes C. T., Railkar A. M., Malick A. W., Shah N. A. Controlled release of drugs from injectable in-situ formed biodegradable PLGA microspheres: effect of formulation variables. Eur. J. Pharm. Biopharm. 2000; 50: 257–262, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Jain R. A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21: 2475–2490, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kranz H., Brazeau G. A., Napaporn J., Martin R. L., Millard W., Bodmeier R. Myotoxicity studies of injectable biodegradable in-situ forming drug delivery system. Int. J. Pharm. 2001; 212: 11–18, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with folin phenol agent. J. Biol. Chem. 1951; 193: 265, [PUBMED], [INFOTRIEVE], [CSA]
  • Matschke C., Isele U., Hoogevest P. V., Fahr A. Sustained release injectables formed in-situ and their potential use for veterinary products. J. Control. Rel. 2002; 85: 1–15, [CSA], [CROSSREF]
  • Moltu F., Laurent A., Rufenacht D. A., Doelker E. Organic solvent for pharmaceutical parenterals and embolic liquids: a review of toxicity data. J. Parent. Sci. Technol. 2000; 54(6)457–469, [CSA]
  • Royals M. A., Fujuta S. M., Yewey G. L., Rodriguez J., Schultheiss P. C., Dunn R. L. Biocompatibility of a biodegradable in-situ forming implant system in rhesus monkeys. J. Biomed. Mater. Res. 1999; 45: 231–239, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Singh U. V., Udupa N., Kamath R., Umadevi P. Enhanced anti-tumor efficacy of methotrexate poly (lactide-co-glycolide) acid injectable gel implants in mice bearing sarcoma—180. Pharm. Sci. 1997; 3: 133–136, [CSA]
  • Yolles S., Eldridge J. E., Woodland J. H. R. Sustained delivery of drugs from polymer drug mixtures. Polymer News 1971; 1: 9–12, [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.